Verus Financial Partners’s Amgen AMGN Stock Holding History

Verus Financial Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,936	Closed	-$1M	–	89
2020 Q3	$1M	Buy	+3,936	New	+$975K	0.36%	55

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Verus Financial Partners's AMGN Position: Q4 2020 in Review

Verus Financial Partners sold out of Amgen (AMGN) in Q4 2020, closing a stake of 3,936 shares — an estimated $1M sold.

Verus Financial Partners first reported a position in AMGN in Q3 2020 and held it in 1 quarter. The position peaked at $1M in Q3 2020. 2,219 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

Verus Financial Partners reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
Verus Financial Partners sold 3,936 Amgen shares in Q4 2020, an estimated $1M.
Verus Financial Partners first reported a position in Amgen in Q3 2020 and held it in 1 quarter.
Verus Financial Partners's Amgen position peaked at $1M in Q3 2020.
2,219 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Verus Financial Partners's 13F filing for Q4 2020, filed 10 Feb 2021.